Pharmacology of danazol
Danazol was found to be an orally active pituitary gonadotrophin inhibitor with weak androgenic activity, lacking oestrogenic and progestational effects, and demonstrated safety in toxicological studies.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
Cited by (13)
- Effects of Danazol on the epididymal function in male langurs (Presbytis entellus entellus Dufresne) 2009
- Induction of true precocious puberty by neonatal treatment with danazol in female rats 1993
- The detection of danazol and its significance in doping analysis 1992
- Glucose tolerance and insulin resistance after danazol treatment 1989
- Free testosterone levels during danazol therapy 1983
- Danazol and gestagen displacement of testosterone and influence on sex-hormone-binding globulin capacity 1982
- Hormonal and Surgical Management of Pelvic Endometriosis 1982
- In vitro effect of danazol on luteinizing hormone-releasing hormone-stimulated luteinizing hormone release in rat anterior pituitary cell cultures in vitro 1981
- Pharmacology and pharmacokinetics of danazol 1980
- Hypertension: a complication of danazol therapy 1980
- Myalgia and elevated creatine phosphokinase with Danazol in hereditary angioedema 1979
- A comparison of plasma protein changes induced by danazol, pregnancy, and estrogens 1979
- Danazol and thyroid function 1979
Source provenance
- openalex
- last seen: 2026-05-10T10:49:45.548917+00:00
- pubmed
- last seen: 2026-10-08T21:51:55.209427+00:00